PKD1 and breast neoplasm: These results are of crucial importance, because 1) they show that daily exposure of mice to low-dose BPA (5 μg/kg/d), similar to the temporary Tolerable Daily Intake established by EFSA (2015), may promote in vivo xenograft breast tumor growth and, more importantly, 2) they identified PKD1 as a key functional target of this process.